CONMED Debt to Equity Ratio 2010-2023 | CNMD
Current and historical debt to equity ratio values for CONMED (CNMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CONMED debt/equity for the three months ending December 31, 2023 was 1.17.
| CONMED Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$1.47B |
$0.83B |
1.76 |
| 2023-09-30 |
$1.53B |
$0.80B |
1.92 |
| 2023-06-30 |
$1.54B |
$0.78B |
1.98 |
| 2023-03-31 |
$1.57B |
$0.75B |
2.08 |
| 2022-12-31 |
$1.55B |
$0.75B |
2.08 |
| 2022-09-30 |
$1.58B |
$0.72B |
2.20 |
| 2022-06-30 |
$1.40B |
$0.67B |
2.08 |
| 2022-03-31 |
$1.00B |
$0.79B |
1.26 |
| 2021-12-31 |
$0.98B |
$0.79B |
1.25 |
| 2021-09-30 |
$1.00B |
$0.76B |
1.32 |
| 2021-06-30 |
$1.02B |
$0.74B |
1.37 |
| 2021-03-31 |
$1.02B |
$0.73B |
1.41 |
| 2020-12-31 |
$1.04B |
$0.71B |
1.47 |
| 2020-09-30 |
$1.06B |
$0.68B |
1.55 |
| 2020-06-30 |
$1.05B |
$0.68B |
1.55 |
| 2020-03-31 |
$1.05B |
$0.70B |
1.50 |
| 2019-12-31 |
$1.07B |
$0.71B |
1.50 |
| 2019-09-30 |
$1.06B |
$0.70B |
1.51 |
| 2019-06-30 |
$1.06B |
$0.70B |
1.52 |
| 2019-03-31 |
$1.07B |
$0.69B |
1.54 |
| 2018-12-31 |
$0.71B |
$0.66B |
1.07 |
| 2018-09-30 |
$0.71B |
$0.65B |
1.09 |
| 2018-06-30 |
$0.72B |
$0.65B |
1.10 |
| 2018-03-31 |
$0.71B |
$0.64B |
1.10 |
| 2017-12-31 |
$0.73B |
$0.63B |
1.15 |
| 2017-09-30 |
$0.77B |
$0.59B |
1.31 |
| 2017-06-30 |
$0.75B |
$0.58B |
1.29 |
| 2017-03-31 |
$0.75B |
$0.58B |
1.31 |
| 2016-12-31 |
$0.75B |
$0.58B |
1.29 |
| 2016-09-30 |
$0.75B |
$0.58B |
1.28 |
| 2016-06-30 |
$0.76B |
$0.58B |
1.31 |
| 2016-03-31 |
$0.76B |
$0.58B |
1.31 |
| 2015-12-31 |
$0.52B |
$0.59B |
0.88 |
| 2015-09-30 |
$0.52B |
$0.58B |
0.90 |
| 2015-06-30 |
$0.51B |
$0.58B |
0.88 |
| 2015-03-31 |
$0.51B |
$0.57B |
0.90 |
| 2014-12-31 |
$0.52B |
$0.58B |
0.89 |
| 2014-09-30 |
$0.52B |
$0.59B |
0.87 |
| 2014-06-30 |
$0.50B |
$0.60B |
0.82 |
| 2014-03-31 |
$0.49B |
$0.60B |
0.82 |
| 2013-12-31 |
$0.48B |
$0.61B |
0.80 |
| 2013-09-30 |
$0.49B |
$0.59B |
0.83 |
| 2013-06-30 |
$0.50B |
$0.59B |
0.85 |
| 2013-03-31 |
$0.49B |
$0.60B |
0.81 |
| 2012-12-31 |
$0.47B |
$0.61B |
0.78 |
| 2012-09-30 |
$0.49B |
$0.60B |
0.81 |
| 2012-06-30 |
$0.47B |
$0.59B |
0.79 |
| 2012-03-31 |
$0.49B |
$0.59B |
0.84 |
| 2011-12-31 |
$0.36B |
$0.57B |
0.63 |
| 2011-09-30 |
$0.39B |
$0.61B |
0.64 |
| 2011-06-30 |
$0.38B |
$0.62B |
0.62 |
| 2011-03-31 |
$0.39B |
$0.60B |
0.65 |
| 2010-12-31 |
$0.40B |
$0.59B |
0.68 |
| 2010-09-30 |
$0.42B |
$0.58B |
0.73 |
| 2010-06-30 |
$0.41B |
$0.58B |
0.71 |
| 2010-03-31 |
$0.41B |
$0.58B |
0.70 |
| 2009-12-31 |
$0.38B |
$0.58B |
0.66 |
| 2009-09-30 |
$0.38B |
$0.57B |
0.67 |
| 2009-06-30 |
$0.37B |
$0.56B |
0.65 |
| 2009-03-31 |
$0.37B |
$0.56B |
0.67 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.189B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
